UEMS Medical Specialty
Obstetrics & Gynaecology
Formulation science for female reproductive health, hormonal balance, PCOS management, and gestational nutrition protocols.
5
dossiers
Female Endocrine-Metabolic Crosstalk
Female Endocrine-Metabolic Axis: Inositols, Antioxidants, and Advanced Formulation Technologies for PCOS
Developing multi-component formulations for female endocrine-metabolic disorders like PCOS requires precise active ingredient ratios, enhanced bioavailability for poorly absorbed compounds, protection of sensitive molecules, and dosage forms that ensure patient compliance.
Female Endocrine-Metabolic Crosstalk
Female Endocrine-Metabolic Axis: Formulation Technologies for Inositols and Antioxidants
Formulating stable, bioavailable, and patient-compliant products with precise inositol isomer ratios and sensitive antioxidants for female endocrine-metabolic health presents challenges in ingredient stability, dissolution, and avoiding paradoxical clinical effects from incorrect dosages.
Female Endocrine-Metabolic Crosstalk
Household Xenoestrogens and Nutritional Interventions: A Translational Endocrine Defense Framework
Designing medical foods that mitigate the effects of chronic, low-dose exposure to diverse endocrine-disrupting chemical mixtures, while adhering to regulatory definitions and ensuring compatibility with polypharmacy risks.
Intracellular Defense & IV-Alternatives
Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.